Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Pharma channel feed
Moderna’s mpox vaccine outperforms approved version in preclinical study
9 months ago
R&D
Court orders J&J to pay $1B following buyout of surgical robotics company
9 months ago
Law
With $200M investment, Novartis builds out radioligand manufacturing at two sites
9 months ago
Manufacturing
Roche unveils more mid-stage data for BTK inhibitor in relapsing multiple sclerosis
9 months ago
R&D
Court's ruling on Illumina-Grail deal could signal a limit to European antitrust powers
9 months ago
Deals
Diagnostics
Pfizer and Valneva say second Lyme booster led to 'strong' responses, target 2026 FDA submission
9 months ago
European Commission revokes Ocaliva's authorization ahead of FDA adcomm
9 months ago
FDA+
Novo Nordisk continues to grapple with patchy GLP-1 drug supply in Europe
9 months ago
Manufacturing
Sanofi’s BTK inhibitor goes 1-for-3 in key MS trials, slows disability progression
9 months ago
R&D
Bayer’s Kerendia cuts heart death, failure and hospitalization by 16% in Phase 3 trial
9 months ago
R&D
FDA authorizes Novavax's updated Covid booster
9 months ago
FDA+
Coronavirus
Novo Nordisk reveals post-hoc cardiovascular data for semaglutide
9 months ago
Ipsen sells priority review voucher for highest price since 2016
9 months ago
FDA+
FDA approves Emergent vaccine for mpox as company plans to donate 50,000 doses
9 months ago
FDA+
Merck opens London lab as it makes push into immunology and the UK
9 months ago
R&D
Novo offers detailed look at semaglutide’s cardiac outcomes in Phase 3 trial as it tees up resubmission
9 months ago
R&D
Pennsylvania judge sides with drugmakers on first steps for growing GLP-1 lawsuits
9 months ago
FDA+
Law
Ahead of acquisition by Novo Holdings, are Catalent’s dark days behind it?
9 months ago
Manufacturing
Merck ends two Phase 3 studies of Keytruda, including an early-stage non-small cell lung cancer trial
9 months ago
R&D
BioMarin lays off 225 employees as it cuts spending on gene therapy rollout
9 months ago
People
UK government partners with pharma on new £400M life science infusion
9 months ago
R&D
Delaware high court to review expert testimony in Zantac suits, in win for drugmakers
9 months ago
Law
Regeneron sues Sandoz to halt biosimilar to its blockbuster eye drug
9 months ago
Law
House Oversight chair tells PBM CEOs to correct testimonies from July hearing
9 months ago
FDA+
First page
Previous page
38
39
40
41
42
43
44
Next page
Last page